New imaging technology detects early signs of heart disease through the skin
2026-01-22
(Press-News.org)
Researchers from Helmholtz Munich and the Technical University of Munich (TUM) have developed “fast-RSOM”, a new imaging technology that can capture detailed images of the smallest blood vessels directly through the skin – without the need for invasive procedures. By revealing early signs of cardiovascular risk, this technology could help doctors intervene sooner, guide personalized therapies, and improve long-term heart health.
A New Window Into Microvascular Health
One of the earliest warning signs of cardiovascular disease happens deep within the smallest blood vessels: tiny changes in their ability to expand and contract, known as microvascular endothelial dysfunction (MiVED). Until now, doctors had no precise and non-invasive way to see or measure these early changes in humans.
“With fast-RSOM, we can, for the first time, non-invasively assess endothelial dysfunction at single-capillary and skin-layer resolution in humans,” says Dr. Hailong He, first author of the study and researcher at the Institute of Biological and Medical Imaging at Helmholtz Munich and TUM. Dr. Angelos Karlas, co-first author, Vascular Surgeon and Senior Research Scientist at TUM University Hospital, adds: “Our novel approach offers an unprecedented view of how cardiovascular disease manifests at the microvascular level.”
Detecting Progression Before Symptoms Appear
Fast-RSOM provides high-resolution, dynamic MiVED biomarkers, describing subtle impairments in blood vessel function, that are generally present before clinical symptoms or measurable macroscopic disease features appear. These early changes are often linked to risk factors such as smoking, high blood pressure, or obesity. However, in contrast to computing risk based on descriptive conditions, fast-RSOM can quantitatively capture the actual changes that these conditions have imposed on the microvascular system – long before major complications develop.
By capturing these early warning signs, fast-RSOM opens up new possibilities for early detection, prevention, and more precise monitoring of cardiovascular health. The technology could help identify individuals at higher risk of developing cardiovascular events with higher precision and monitor lifestyle or therapeutic interventions.
Towards Clinical Application
The research team now aims to validate fast-RSOM in larger and more diverse patient groups and to integrate its biomarkers into clinical workflows. Because the device is portable, fast, and non-invasive, it could one day be used in outpatient clinics for routine cardiovascular risk assessment.
“By enabling earlier interventions and more precise monitoring, fast-RSOM could transform how cardiovascular diseases are prevented and managed – improving outcomes for patients and reducing healthcare costs in the long term,” says Prof. Vasilis Ntziachristos, Director of the Bioengineering Center at Helmholtz Munich and Professor for Biological Imaging at TUM.
What is RSOM?
RSOM (Raster Scan Optoacoustic Mesoscopy) is a non-invasive imaging technology that uses pulses of light to generate ultrasound signals, producing highly detailed 3D images of structures beneath the skin. It can detect tiny changes in blood vessels, oxygen levels, and tissue composition that are invisible to traditional imaging. By combining high contrast with depth, RSOM enables early detection of diseases such as cardiovascular problems and diabetes. Its compact design could make advanced diagnostics more accessible outside specialized labs. The technology was developed by the team under Vasilis Ntziachristos.
About the Researchers
Dr. Hailong He, researcher at the Institute of Biological and Medical Imaging at Helmholtz Munich and at the Technical University of Munich (TUM).
Dr. Angelos Karlas, Board-Certified (Germany) Vascular Surgeon and Senior Research Scientist at the Clinic and Polyclinic for Vascular and Endovascular Surgery at the TUM University Hospital, Hospital Rechts der Isar, in Munich, Germany. He also serves as the Clinical Research Lead at the Chair for Computer-Aided Medical Procedures and Augmented Reality at the Technical University of Munich (TUM).
Prof. Vasilis Ntziachristos is the Director of the Bioengineering Center and the Director of Institute of Biological and Medical Imaging at Helmholtz Munich. He also holds the Chair of Biological Imaging at the Technical University of Munich (TUM) and is a founding member and in the Board of Directors of TranslaTUM, TUM's Central Institute for Translational Cancer Research. He is affiliated with Munich partner site of the German Centre for Cardiovascular Research (DZHK).
About Helmholtz Munich
Helmholtz Munich is a leading biomedical research center. Its mission is to develop breakthrough solutions for better health in a rapidly changing world. Interdisciplinary research teams focus on environmentally triggered diseases, especially the therapy and prevention of diabetes, obesity, allergies, and chronic lung diseases. With the power of artificial intelligence and bioengineering, researchers accelerate the translation to patients. Helmholtz Munich has more than 2,550 employees and is headquartered in Munich/Neuherberg. It is a member of the Helmholtz Association, with more than 46,000 employees and 18 research centers the largest scientific organization in Germany. More about Helmholtz Munich (Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH): www.helmholtz-munich.de/en
END
ELSE PRESS RELEASES FROM THIS DATE:
2026-01-22
By resurrecting a 3.2-billion-year-old enzyme and studying it inside living microbes, researchers at the University of Wisconsin–Madison have created a new way to improve our understanding of the origins of life on Earth and possibly recognize signs of life elsewhere.
Recently published in Nature Communications, the NASA-funded study uses synthetic biology to reverse-engineer modern enzymes and rebuild their possible ancestors. Betül Kaçar, a professor of bacteriology, and Holly Rucker, a PhD candidate in Kaçar’s lab, focused on an enzyme called nitrogenase, which is critical to the process that converts atmospheric nitrogen into a form usable by living ...
2026-01-22
WASHINGTON—People with obesity and high blood pressure may face a higher risk of dementia, according to a new study published in The Journal of Clinical Endocrinology & Metabolism.
Dementia is a growing global public health challenge, with no cure currently available. People with dementia experience a severe decline in mental abilities, like memory, thinking and reasoning.
The most common forms of dementia are Alzheimer's disease, vascular dementia and mixed dementia. Dementia is a progressive brain ...
2026-01-22
New “AI GYM for Science” dramatically boosts the biological and chemical intelligence of any causal or frontier LLM, delivering up to 10x performance gains on key drug discovery benchmarks and advancing the company’s vision of Pharmaceutical Superintelligence (PSI).
CAMBRIDGE, Mass., January 22, 2026 – Insilico Medicine (“Insilico”, HKEX: 3696), a leading global AI-driven biotech company, today announced the launch of Science MMAI Gym, also branded as Insilico Medicine’s AI GYM for Science, a domain-specific training environment designed to transform ...
2026-01-22
DALLAS, Jan. 22, 2026 — The American Stroke Association, a division of the American Heart Association has expanded it’s International Stroke Conference with multiple pre-conference symposiums in 2026. The meeting is in New Orleans, Feb. 4-6, 2026, and is a world premier global event dedicated to advancing stroke and brain health science.
The following is a list of all the pre-conference symposiums:
State-of-the-Science Stroke Nursing Symposium Pre-Conference Symposium - Feb. 3, 2026; 8:00 a.m. to 5:00 p.m. CT
This forum provides updates on nursing topics related to stroke care, including prevention, management, ...
2026-01-22
UNIVERSITY PARK, Pa. — Artificial intelligence (AI) is said to be a “black box,” with its logic obscured from human understanding — but how much does the average user actually care to know how AI works? It depends on the extent to which a system meets users’ expectations, according to a new study by a team that includes Penn State researchers. Using a fabricated algorithm-driven dating website, the team found that whether the system met, exceeded or fell short of user expectations directly corresponded to how ...
2026-01-22
Background and Aims
Bacterial infections (BIs) are common and severe complications in patients with liver cirrhosis, but global data are limited. Here, we aimed to evaluate the global prevalence, temporal changes, and associated mortality risk of BIs in liver cirrhosis.
Methods
We systematically searched PubMed, Embase, Web of Science, and the Cochrane Library for eligible studies published without language restrictions until 11 August 2025. A random-effects model was used for meta-analyses, meta-regression by study year, and pooling adjusted hazard ratios.
Results
Fifty-nine studies, including 1,191,421 patients with cirrhosis, were analyzed. The pooled prevalence of BIs (33 studies) ...
2026-01-22
Predicting the duration of a Central Pacific El Niño event has long frustrated climate scientists and forecasters. Now, a new study reveals that Central Pacific El Niños follow two fundamentally different life cycles—and the difference is determined months before they peak.
The research group, led by Prof. Xin Wang from the South China Sea Institute of Oceanology, Chinese Academy of Sciences, China, shows that strong Central Pacific El Niño events essentially self-destruct by triggering negative feedbacks from the distant Indian and Atlantic Oceans. Weaker events, however, survive by forming a lasting partnership with a regional North Pacific climate ...
2026-01-22
Electric vehicles (EVs) are gaining unprecedented popularity across the globe, with their number reaching 26 million in 2022 and expected to grow eightfold by the end of the decade. While EVs represent the next-generation technology for transport decarbonization, they are expected to lead to the issue of retired battery management. Notably, EV batteries are utilized only until their capacity reduces to 70-80%, meaning an average lifespan of 8-to-10 years. Therefore, the volume of retired batteries is going to rise rapidly by 2030.
To mitigate this problem, scientists have ingeniously come up with ...
2026-01-22
Researchers from the Shanghai University of Medicine & Health Sciences, Tongji University, Royal Melbourne Institute of Technology University, Fudan University, and the University of Sydney synthesize years of proprioception research with frontier bionic evidence such as osseointegrated neural prosthetics, to propose a disruptive framework of the reconceptualization of proprioception. Their findings were made available online in the Journal of Sport and Health Science on January 01, 2026.
Led by Professor Jia Han from the Shanghai University of Medicine & Health Sciences, Tongji University, ...
2026-01-22
Africa confronts escalating internal migration and displacement crises fueled by intensifying climate hazards—particularly prolonged droughts—and persistent armed conflicts, which compound vulnerabilities across the continent. Previous research clearly links these stressors to heightened population movements, but limited empirical work examines climate adaptation's role, especially agriculture's influence, in moderating these effects at grid and country levels.
On this premise, a study led by Professor Hyun Kim, Associate Professor in the School of Public Administration at Chungnam National ...
LAST 30 PRESS RELEASES:
[Press-News.org] New imaging technology detects early signs of heart disease through the skin
